Table 1.

Availability of essential COVID-19 tools and other essential health products in hospitals (n = 498, 18 countries) and primary care facilities (n = 2,377, 21 countries) at the time of assessment, by country (January 2021–March 2022).

	Hospitals					Primary care
	% of facilities with PPE for all staff	% of facilities with onsite RDT and/or PCR for COVID-19 diagnosis	Average availability of therapeutics to treat COVID-19	% of facilities with functioning invasive and/or non-invasive ventilators	% of facilities with available oxygen	% of facilities with PPE for all staff	Average availability of essential diagnostics a	Average availability of essential therapeutics b	% of facilities with available oxygen
Burundi	31	80	64	69	80	47	89	44	No data
Cameroon	18	62	63	55	75	40	75	65	No data
Chad	33	33	58	67	100	36	47	46	18
Congo	21	55	50	58	48	26	48	35	No data
Ghana	37	55	68	63	97	60	34	49	57
Kenya	21	53	59	96	99	12	60	55	14
Mali	36	0	74	100	100	57	80	55	29
Namibia	67	54	87	74	95	67	42	74	70
Senegal	36	100	63	93	93	60	95	71	51
Seychelles	No data	No data	No data	No data	No data	90	41	58	74
Zambia	56	96	68	64	100	47	72	58	32
Paraguay	95	95	87	100	100	25	No data	44	64
Peru	69	92	88	83	100	86	71	68	96
St. Lucia	No data	100	93	100	100	79	59	66	93
St. Vincent	100	100	80	100	100	71	44	62	93
Suriname	11	33	61	89	89	41	No data	No data	No data
Afghanistan	80	40	80	100	100	73	49	67	91
Libya	40	50	61	100	80	28	34	27	73
Yemen	87	87	59	100	91	68	65	51	80
Moldova	No data	No data	No data	No data	No data	99	65	75	78
Ukraine	No data	No data	No data	No data	No data	88	73	63	35
Average	49	66	70	84	92	57	60	57	62
91% or more	80–90%	65–79%	50–64%	Less than 50%	No data

^aDiagnostics for blood glucose, urine glucose, urine protein, pregnancy, HIV, TB, HBG, and bloodtype (as appropriate for facility type).

^bSee Annex 3 for therapeutics list.